Local ischemia in the cerebra leads to vascular injury and necrosis. Ferroptosis is involved in the pathophysiological process of many diseases and widely exists when ischemia-reperfusion injury occurs in many organs. The aim of this study was to evaluate the effect of Butylphthalide (NBP) on middle cerebral artery occlusion (MCAO) rats model-caused neuron injury. Sprague Dawley Rats were randomly allocated to receive sham and MCAO operation. NBP low-dose (40 mg/kg b.w), and high-dose (80 mg/kg b.w) were administrated in MACO rats. Results showed NBP improves infarct volume, attenuates neuronal apoptosis in the brain tissue of MCAO rats. The tumor necrosis factor (TNF-α), IL-6, and malondialdehyde (MDA) levels decreased after NBP administration, while the activity of superoxide dismutase (SOD) and the ratio of GSH/GSSG in MACO rats increased. MACO caused non-heme iron accumulation in the brain tissue and Perl’s staining confirmed NBP attenuates ferroptosis in MACO rats. The protein expressions of SCL7A11 and glutathione peroxidase 4 (GPX4) decreased following MCAO, and NBP treatment subsequently increased the expression of SCL7A11 and GPX4. In vitro analysis in cortical neuron cells indicated that the GPX4 inhibitor reverses the inhibition of ferroptosis by NBP, which suggested that the SCL7A11/GPX4 pathway majorly contributed to the NBP ferroptosis protection effect.
JensenMThomallaG.Causes and secondary prevention of acute ischemic stroke in adults. Hamostaseologie2020; 40: 22–30.
3.
ChenYFanHWangS, et al. Ferroptosis: a novel therapeutic target for ischemia-reperfusion injury. Front Cell Dev Biol2021; 9: 688605.
4.
YanHFTuoQZYinQZ, et al. The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res2020; 41: 220–230.
5.
MaoHDouWChenK, et al. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping. Neuroimage Clin2022; 34: 103021.
6.
HelbokRRassVKoflerM, et al. Intracerebral iron accumulation may be associated with secondary brain injury in patients with poor grade subarachnoid hemorrhage. Neurocrit Care2022; 36: 171–179.
7.
KinutaYKikuchiHIshikawaM, et al. Lipid peroxidation in focal cerebral ischemia. J Neurosurg1989; 71: 421–429.
8.
BayirHAnthonymuthuTSTyurinaYY, et al. Achieving life through death: redox biology of lipid peroxidation in ferroptosis. Cell Chem Biol2020; 27: 387–408.
9.
LiQHanXLanX, et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight2017; 2: e90777.
10.
Santiago GonzalezDACheliVTWanR, et al. Iron metabolism in the peripheral nervous system: the role of DMT1, ferritin, and transferrin receptor in schwann cell maturation and myelination. J Neurosci2019; 39: 9940–9953.
11.
LiuXChenCHanD, et al. SLC7A11/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxidative Med Cell Long2022; 2022: 3192607.
12.
WangCFWangZYLiJY.Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies. World J Gastroenterol2011; 17: 3101–3108.
13.
NittiMPirasSBrondoloL, et al. Heme oxygenase 1 in the nervous system: does it favor neuronal cell survival or induce neurodegeneration?Int J Mol Sci2018; 19: 2260.
14.
ChenTLiuWChaoX, et al. Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Res Bull2011; 84: 163–168.
15.
AlamJIgarashiKImmenschuhS, et al. Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase. Antioxid Redox Signal2004; 6: 924–933.
16.
LobodaADamulewiczMPyzaE, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci2016; 73: 3221–3247.
17.
WangSMaFHuangL, et al. Dl-3-n-butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. CNS Neurol Disord Drug Targets2018; 17: 338–347.
18.
JinRZhuXLiG.Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats. J Vis Exp2014; 91: 51956.
19.
ZhangLWangHWangT, et al. Ferulic acid ameliorates nerve injury induced by cerebral ischemia in rats. Exp Ther Med2015; 9: 972–976.
20.
ZhangSXinHLiY, et al. Skimmin, a coumarin from hydrangea paniculata, slows down the progression of membranous glomerulonephritis by anti-inflammatory effects and inhibiting immune complex deposition. Evid Based Complement Alternat Med2013; 2013: 819296.
21.
SenZWeidaWJieM, et al. Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2/3-mediated profibrosis. Phytomedicine2019; 57: 385–395.
22.
WangZYaoMJiangL, et al. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis. Biomed Pharmacother2022; 154: 113572.
23.
ZhangYRenYChenX, et al. Role of Butylphthalide in immunity and inflammation: butylphthalide may be a potential therapy for anti-inflammation and immunoregulation. Oxid Med Cell Longev2022; 2022: 7232457.
24.
ChenXQQiuKLiuH, et al. Application and prospects of butylphthalide for the treatment of neurologic diseases. Chin Med J (Engl)2019; 132: 1467–1477.
25.
HarriganMDeveikisJ.Intracranial cerebrovascular occlusive disease. Humana Totowa, NJ. 2013, pp. 779–802.
26.
DittmarMSprussTSchuiererG, et al. External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats. Stroke2003; 34: 2252–2257.
27.
BatesERTopolEJ.Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol1991; 18: 1077–1084.
28.
SunMSJinHSunX, et al. Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev2018; 2018: 3804979.
29.
Samhan-AriasAKTyurinaYYKaganVE.Lipid antioxidants: free radical scavenging versus regulation of enzymatic lipid peroxidation. J Clin Biochem Nutr2011; 48: 91–95.
30.
ChangXZhangTZhangW, et al. Natural drugs as a treatment strategy for cardiovascular disease through the regulation of oxidative stress. Oxid Med Cell Longev2020; 2020: 5430407.
31.
LiJCaoFYinHL, et al. Ferroptosis: past, present and future. Cell Death Dis2020; 11: 88.
32.
CaoJYDixonSJ.Mechanisms of ferroptosis. Cell Mol Life Sci2016; 73: 2195–2209.
33.
ForcinaGCDixonSJ.GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics2019; 19: e1800311.
34.
HuangYDaiZBarbacioruC, et al. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res2005; 65: 7446–7454.
GillDMonoriGTzoulakiI, et al. Iron status and risk of stroke. Stroke2018; 49: 2815–2821.
37.
KajarabilleNLatunde-DadaGO.Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci2019; 20: 4968.
38.
ByrnesKRLoaneDJFadenAI.Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics2009; 6: 94–107.
39.
SedlakTWPaulBDParkerGM, et al. The glutathione cycle shapes synaptic glutamate activity. Proc Natl Acad Sci USA2019; 116: 2701–2706.
